77 related articles for article (PubMed ID: 16964965)
21. Transcriptional response of pancreatic beta cells to metabolic stimulation: large scale identification of immediate-early and secondary response genes.
Glauser DA; Brun T; Gauthier BR; Schlegel W
BMC Mol Biol; 2007 Jun; 8():54. PubMed ID: 17587450
[TBL] [Abstract][Full Text] [Related]
22. D-glucose‑ and 3-O-methyl-D-glucose-induced upregulation of selected genes in rat hepatocytes and INS1E cells: re‑evaluation of the possible role of hexose phosphorylation.
Svoboda M; Tastenoy M; Zhang Y; Gillet C; Rasschaert J; Malaisse WJ; Sener A
Mol Med Rep; 2013 Sep; 8(3):829-36. PubMed ID: 23846350
[TBL] [Abstract][Full Text] [Related]
23. Hyperglycemia-induced thioredoxin-interacting protein expression differs in breast cancer-derived cells and regulates paclitaxel IC50.
Turturro F; Von Burton G; Friday E
Clin Cancer Res; 2007 Jun; 13(12):3724-30. PubMed ID: 17575238
[TBL] [Abstract][Full Text] [Related]
24. A potential mechanism of metformin-mediated regulation of glucose homeostasis: inhibition of Thioredoxin-interacting protein (Txnip) gene expression.
Chai TF; Hong SY; He H; Zheng L; Hagen T; Luo Y; Yu FX
Cell Signal; 2012 Aug; 24(8):1700-5. PubMed ID: 22561086
[TBL] [Abstract][Full Text] [Related]
25. Exendin-4 induction of Egr-1 expression in INS-1 beta-cells: interaction of SRF, not YY1, with SRE site of rat Egr-1 promoter.
Kim MJ; Kang JH; Chang SY; Jang HJ; Ryu GR; Ko SH; Jeong IK; Kim MS; Jo YH
J Cell Biochem; 2008 Aug; 104(6):2261-71. PubMed ID: 18446785
[TBL] [Abstract][Full Text] [Related]
26. Regulation of insulin gene expression and insulin production in Nile tilapia (Oreochromis niloticus).
Hrytsenko O; Wright JR; Pohajdak B
Gen Comp Endocrinol; 2008 Jan; 155(2):328-40. PubMed ID: 17618629
[TBL] [Abstract][Full Text] [Related]
27. Geniposide accelerates proteasome degradation of Txnip to inhibit insulin secretion in pancreatic β-cells.
Liu CY; Hao YN; Yin F; Zhang YL; Liu JH
J Endocrinol Invest; 2017 May; 40(5):505-512. PubMed ID: 28000177
[TBL] [Abstract][Full Text] [Related]
28. W2476 ameliorates β-cell dysfunction and exerts therapeutic effects in mouse models of diabetes via modulation of the thioredoxin-interacting protein signaling pathway.
Li T; Lin GY; Zhong L; Zhou Y; Wang J; Zhu Y; Feng Y; Cai XQ; Liu Q; Nosjean O; Boutin JA; Renard P; Yang DH; Wang MW
Acta Pharmacol Sin; 2017 Jul; 38(7):1024-1037. PubMed ID: 28502980
[TBL] [Abstract][Full Text] [Related]
29. Sp1-mediated transcription is involved in the induction of leptin by insulin-stimulated glucose metabolism.
Moreno-Aliaga MJ; Swarbrick MM; Lorente-Cebrián S; Stanhope KL; Havel PJ; Martínez JA
J Mol Endocrinol; 2007 May; 38(5):537-46. PubMed ID: 17496155
[TBL] [Abstract][Full Text] [Related]
30. Glucose, regulator of survival and phenotype of pancreatic beta cells.
Martens GA; Pipeleers D
Vitam Horm; 2009; 80():507-39. PubMed ID: 19251048
[TBL] [Abstract][Full Text] [Related]
31. Thioredoxin interacting protein (TXNIP) induces inflammation through chromatin modification in retinal capillary endothelial cells under diabetic conditions.
Perrone L; Devi TS; Hosoya K; Terasaki T; Singh LP
J Cell Physiol; 2009 Oct; 221(1):262-72. PubMed ID: 19562690
[TBL] [Abstract][Full Text] [Related]
32. Palmitate and insulin counteract glucose-induced thioredoxin interacting protein (TXNIP) expression in insulin secreting cells via distinct mechanisms.
Panse M; Kluth O; Lorza-Gil E; Kaiser G; Mühlbauer E; Schürmann A; Häring HU; Ullrich S; Gerst F
PLoS One; 2018; 13(5):e0198016. PubMed ID: 29813102
[TBL] [Abstract][Full Text] [Related]
33. Exendin-4 inhibits interleukin-1beta-induced iNOS expression at the protein level, but not at the transcriptional and posttranscriptional levels, in RINm5F beta-cells.
Kang JH; Chang SY; Jang HJ; Kim DB; Ryu GR; Ko SH; Jeong IK; Jo YH; Kim MJ
J Endocrinol; 2009 Jul; 202(1):65-75. PubMed ID: 19398497
[TBL] [Abstract][Full Text] [Related]
34. The transcription factor PAX4 acts as a survival gene in INS-1E insulinoma cells.
Brun T; Duhamel DL; Hu He KH; Wollheim CB; Gauthier BR
Oncogene; 2007 Jun; 26(29):4261-71. PubMed ID: 17260022
[TBL] [Abstract][Full Text] [Related]
35. Lack of TXNIP protects beta-cells against glucotoxicity.
Shalev A
Biochem Soc Trans; 2008 Oct; 36(Pt 5):963-5. PubMed ID: 18793170
[TBL] [Abstract][Full Text] [Related]
36. Effect of taurine on mRNA expression of thioredoxin interacting protein in Caco-2 cells.
Gondo Y; Satsu H; Ishimoto Y; Iwamoto T; Shimizu M
Biochem Biophys Res Commun; 2012 Sep; 426(3):433-7. PubMed ID: 22960072
[TBL] [Abstract][Full Text] [Related]
37. Pancreatic fate of 14C-labelled hexoses.
Malaisse WJ; Ladriere L; Kadiata MM; Malaisse-Lagae F
Cell Biochem Funct; 2000 Dec; 18(4):281-91. PubMed ID: 11180291
[TBL] [Abstract][Full Text] [Related]
38. Gene expression profiling in INS-1 cells overexpressing thioredoxin-interacting protein.
Minn AH; Pise-Masison CA; Radonovich M; Brady JN; Wang P; Kendziorski C; Shalev A
Biochem Biophys Res Commun; 2005 Oct; 336(3):770-8. PubMed ID: 16143294
[TBL] [Abstract][Full Text] [Related]
39. MondoA senses non-glucose sugars: regulation of thioredoxin-interacting protein (TXNIP) and the hexose transport curb.
Stoltzman CA; Kaadige MR; Peterson CW; Ayer DE
J Biol Chem; 2011 Nov; 286(44):38027-38034. PubMed ID: 21908621
[TBL] [Abstract][Full Text] [Related]
40. Preventing β-cell loss and diabetes with calcium channel blockers.
Xu G; Chen J; Jing G; Shalev A
Diabetes; 2012 Apr; 61(4):848-56. PubMed ID: 22442301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
